After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CRNX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Crinetics Pharmaceuticals Inc is $3.23B. A total of 0.69 million shares were traded on the day, compared to an average of 995.42K shares.
In the most recent transaction, Pizzuti Dana sold 2,515 shares of CRNX for 34.20 per share on Mar 19 ’25. After the transaction, the Chief Med and Dev Officer now owns 72,233 company shares. In a previous transaction on Mar 19 ’25, Knight Jeff E. sold 7,162 shares at 34.20 per share. CRNX shares that Chief Operating Officer owns now total 87,491.
Among the insiders who sold shares, Betz Stephen F. disposed of 5,770 shares on Mar 19 ’25 at a per-share price of $34.20. This resulted in the Chief Scientific Officer holding 108,588 shares of CRNX after the transaction. In another insider transaction, Struthers Richard Scott sold 17,338 shares at $34.20 per share on Mar 19 ’25. Company shares held by the President & CEO now total 329,147.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRNX has a high of $62.53 and a low of $31.84.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRNX’s latest balance sheet shows that the firm has $333.71M in Cash & Short Term Investments as of fiscal 2021. There were $3.07M in debt and $15.99M in liabilities at the time. Its Book Value Per Share was $14.26, while its Total Shareholder’s Equity was $331.94M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRNX is Buy with a score of 4.88.
